Active Studies

Showing 21-30 trials of 198 total

• Blood Disorders

  Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

  This trial is currently enrolling

  The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about ...

• Blood Disorders

  Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation

  This trial is currently enrolling

  This protocol will collect blood samples and medical information from patients who have had a bone marrow transplant using cells from an unrelated donor identified through the National Marrow Donor Program (NMDP). The NMDP has two programs in which patients can participate: the Research Database ...

• Cancer

  Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors (An NMDP Protocol)

  This trial is currently enrolling

  The purpose of the study is to: - Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors - Assess the safety among NMDP donors of filgrastim administration and PBSC leukapheresis - Assess the ...

• Cardiology and Vascular Diseases

  The PARTNER Trial: Placement of AoRTic TraNscathetER Valves Trial with Continued Access and with Post-Approval Study [Edwards Study # 2006-06-US]

  This trial is not currently enrolling

  The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems: NovaFlex (transfemoral access) and Ascendra2 (transapical access) in patients with symptomatic, calcific, severe aortic stenosis.

• Genetics

  The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry [STSI]

  This trial is not currently enrolling

  By creating a neurogenebank from Parkinson’s disease patients’ blood donations we will ultimately be able to define genes for Parkinson’s disease and other neurological conditions.

• Genetics

  Scripps Genomic Health Initiative

  This trial is not currently enrolling

  The specific aims for this project are to enroll up to 10,000 subjects who will have their genomes surveyed using the Navigenics™ Health Compass technology. The Navigenics Health Compass helps you understand what your genetic variants have to say about the future of your health, and gives you ...

• Genetics

  Biorepository for Scripps Health [STSI]

  This trial is currently enrolling

  The investigators propose to establish a Biorepository of both diseased and normal tissue collected from subjects undergoing surgery for solid tumor resection. In cooperation with the Scripps Cancer registry, the investigators will also establish an anonymized database of corresponding clinical ...

• Cardiology and Vascular Diseases

  Comprehensive Molecular and Morphologic Characterization of Circulating Endothelial Cells

  This trial is currently enrolling

  The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.

• Transplant - Organ and Tissue

  Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants

  This trial is not currently enrolling

  The goal of this research program is to understand the natural history of asymptomatic bacteriuria in the renal transplant patients, to determine if screening for asymptomatic bacteriuria and identification of key host characteristics and virulence factors present on uropathogenic bacteria ...

• Cancer

  A Multi-center, Phase 2, Single-Arm, Open-Label Exploratory Study of Individually-Optimized Conditioning Using Pharmacokinetics [PK]-directed Dose Adjustment of Once Daily Intravenous Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant in Subjects with Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma, Otsuka Protocol No. 273-08-201

  This trial is not currently enrolling

  This is a study for the outcome and safety of individualized busulfan dosing with cyclophosphamide and etoposide for patients preparing for a stem cell transplant to treat Non-Hodgkin or Hodgkin’s Lymphoma.